Vivani Medical (VANI) Capital Expenditures (2014 - 2026)

Vivani Medical has reported Capital Expenditures for 13 years, with the latest figure at $99000.0 in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 39.44% year-over-year to $99000.0 in Q2 2026; TTM through Jun 2026 was $1.2 million, a 190.31% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 110.97% from the prior year.
• Capital Expenditures was $99000.0 for Q2 2026 at Vivani Medical, up from $3000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $823000.0 in Q3 2025, with the low at $3000.0 in Q1 2026.
• Average Capital Expenditures over 5 years is $169777.8, with a median of $78500.0 recorded in 2022.
• The largest YoY upside for Capital Expenditures was 1907.32% in 2025 against a maximum downside of 97.25% in 2025.
• Over 5 years, Capital Expenditures stood at $89000.0 in 2022, then soared by 734.83% to $743000.0 in 2023, then sank by 60.16% to $296000.0 in 2024, then decreased by 7.43% to $274000.0 in 2025, then sank by 63.87% to $99000.0 in 2026.
• The last three Capital Expenditures figures came in at $99000.0 (Q2 2026), $3000.0 (Q1 2026), and $274000.0 (Q4 2025), per Business Quant data.